Vaccines, blood, antisera, toxins and cultures in   Nepal

Exports In 2022, Nepal exported $2.57M in Vaccines, blood, antisera, toxins and cultures, making it the 90th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 67th most exported product in Nepal. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Nepal are: United States ($551k), Algeria ($542k), Niger ($423k), China ($372k), and Guinea ($194k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Nepal between 2021 and 2022 were Niger ($423k), United States ($378k), and Guinea ($194k).

Imports In 2022, Nepal imported $195M in Vaccines, blood, antisera, toxins and cultures, becoming the 82nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most imported product in Nepal. Nepal imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($92.4M), Belgium ($33.7M), India ($26.5M), China ($21M), and United Kingdom ($8.6M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Nepal between 2021 and 2022 were United States ($28.4M), United Kingdom ($7.12M), and Netherlands ($2.09M).